| EDWARDS LIFESCIENCES |
| USA |
| Gesundheit |
| US28176E1082 / 936853 |
| EWL (Frankfurt) / EW (NYSE) |
| FRA:EWL, ETR:EWL, EWL:GR, NYSE:EW |
| S&P500 |
| https://www.edwards.com/ |
|
Edwards Lifesciences Corporation is the leading global structural heart innovation company, specializing in patient-focused medical devices for structural heart disease, critical care, and surgical monitoring. The company develops and commercializes ..
>Volltext.. |
| 40886.42 Mio. EUR |
| 37889.6 Mio. EUR |
| 5256.45 Mio. EUR |
| 1548.02 Mio. EUR |
| 918.38 Mio. EUR |
| 1.57 EUR |
| 611.1 Mio. EUR |
| 2545.67 Mio. EUR |
| 1381.95 Mio. EUR |
| 2.33 |
| -6.57% |
| 6.83% |
| - |
| - |
| - |
| EDWARDS LIFESCIENCES, EDWARDS LIFE |
| 05.04.26 |
|